The Al Jalila Foundation, a member of the Mohammed Bin Rashid Al Maktoum Global Initiatives, dedicated to transforming lives through medical innovation, today announced its partnership with Fundación Iker Casillas and IDOVEN to improve heart health monitoring through to the use of technology, artificial intelligence and innovation applied to health to improve lives.
In collaboration with the Al Jalila Foundation, the parties will conduct a pilot study to monitor the heart health of a cohort of 100 people who will undergo a thorough professional medical evaluation and provide their “heart rhythm data” to contribute to research and prevention of sudden death among groups at high risk of heart disease.
Fundación Iker Casillas is a non-profit entity chaired by world football legend Iker Casillas who created the foundation to support, promote and develop activities that contribute to improving health and quality of life. IDOVEN is a Madrid-based European HealthTech startup that seeks to prevent heart disease, myocardial infarction and sudden death.
According to the World Health Organization, cardiovascular disease is the leading cause of death worldwide with nearly 20 million lives lost each year. It is also the leading cause of death in the United Arab Emirates, contributing 30% of deaths annually. The partnership aims to reduce preventable heart disease.
Dr. Abdulkareem Al Olama, CEO of the Al Jalila Foundation, welcomed Iker Casillas, the founder of the Fundación Iker Casillas, and Dr. Manuel Marina Breysse, CEO and co-founder of IDOVEN, and took them to visit the Mohammed Bin Rashid Medical Research Institute and informed them of the Foundation’s education and research programs.
Dr. Abdulkareem Sultan Al Olama, CEO of Al Jalila Foundation, said: “From telemedicine to artificial intelligence and robotic surgery, technology is revolutionizing the healthcare sector. Advances in medical technology are beyond anything we could have imagined. These innovations have allowed us to advance the treatment of patients and, in some cases, predict the onset of diseases to prevent serious complications and even premature death. Today, thanks to advances in medical research, people are living longer and healthier lives. With remote patient monitoring, doctors can now know what is happening with a patient without being physically close. This pilot study will give us new insights into preventing heart attacks and other heart problems, which can help save lives and benefit millions of people.
The partnership will pioneer the implementation of automated cardiac diagnostic systems, enabling the future of remotely monitoring patients with scalable technology while contributing to cardiovascular disease research and prevention in the UAE .
Iker Casillas, founder of Fundación Iker Casillas, said: “I am proud to promote prevention and health beyond the borders of my country. Thanks to the Al Jalila Foundation, today I can strengthen my Foundation’s commitment to reducing heart disease. Through this alliance with IDOVEN and its artificial intelligence, we will achieve more accessible health and a healthier population in the UAE.
Dr. Manuel Marina Breysse, Chief Executive Officer and Co-Founder of IDOVEN SL, said, “At IDOVEN, we are proud to collaborate with the Al Jalila Foundation and Fundación Iker Casillas in bringing our heart technology to the United Arab Emirates. We are confident that this project will contribute to the health and well-being of the country’s diverse population to support the UAE National Health Strategy and its drive to deliver innovative health programs to its people.
Since its inception in 2013, the Al Jalila Foundation has created opportunities to increase innovative and impactful medical research by investing AED28 million to award 100 research grants and nine international research fellowships to discover solutions to the greatest challenges. of health in the region: cancer, cardiovascular disease, diabetes, obesity. , mental health and emerging diseases. In 2021, the Mohammed Bin Rashid Institute of Medical Research, an affiliate of the Al Jalila Foundation, pledged annual funding of AED 8 million to Mohammed Bin Rashid University of Medicine and Health Sciences to advance biomedical research.
For more information on the Al Jalila Foundation, please visit www.aljalilafoundation.ae.